News

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the ...
According to a recent article,“Behçet's disease is rare, with prevalence estimates varying from 0.12 to 7.5 per 100,000 in the United States and Eur ...
Soligenix (NASDAQ: SNGX) , a late-stage biopharmaceutical company targeting rare diseases, was spotlighted in a July 10 Zacks Small-Cap Research repo ...
The funds were awarded through the Biomedical Advanced Research and Development Authority, or BARDA, a program that focuses on medical treatments for potential pandemics.
IRVINE, Calif., July 1, 2025 /PRNewswire/ — University Lab Partners (ULP) is proud to announce the winners of the inaugural I ...
Detailed price information for Salarius Pharmaceuticals Inc (SLRX-Q) from The Globe and Mail including charting and trades.
Today, anthrax remains one of the deadliest and easiest biological weapons to produce. Yet 80 percent of the U.S. supply of ...
A biotech startup's substantial funding round signals growing interest in domestic production of critical medicine components.
Qatar National Vision 2030 sees the government working to diversify the country’s economy away from hydrocarbons, in the process enhancing the knowledge-based economy. To achieve that goal, the govern ...
The company has also received QuickFire Challenge award funding provided by the Biomedical Advanced Research and Development Authority (BARDA) through BLUE KNIGHT™, a collaboration between ...
Lumos Diagnostics' shares more than doubled in value in afternoon trade after the biotech announced a US$317 million ($487 ...